Authors



Song Lee, PharmD

Latest:

Viability of a Dose Optimization Program Within a Specialty Pharmacy

Dose optimization strategies offer a potentially valid, clinically based intervention in which payers can realize a direct drug cost savings, and indirect medical cost avoidance.



Tony Berberabe, MPH, OncLive

Latest:

FDA to Review NDA for Metastatic Prostate Cancer Drug

Enzalutamide (Xtandi) capsules treats patients with metastatic castration-resistant prostate cancer.


Rama P. Nair, RPh

Latest:

10 Strategies for Minimizing Dispensing Errors

Dispensing errors can be costly for the pharmacist as well as potentially dangerous for the patient. Pharmacists can take simple steps to help eliminate this problem.


Allison Gilchrist

Latest:

Why Pharmacists Should Recommend Asthma Spacers

Pharmacists should recommend asthma spacers to patients taking inhaler therapy for uncontrolled asthma because the devices can help improve hand-breath coordination while reducing side effects of inhaled medication.


Manuel Gonzalez Fernandez

Latest:

Together Beyond COVID-19: A Look at the Future of the Pharmaceutical Industry

In a short time, COVID-19 has increased our dependency on technology and pharmaceutical companies are actively investigating this digital transformation.


Jennifer DiSanto

Latest:

Bevacizumab Intravitreal Injection Intraocular Pressure Found Safe, Tolerable

Increase in intraocular pressure found to be tolerable to the corneal endothelium and safe for treating central serous chorioretinopathy or diabetic macular edema.


Kristen Pate, PharmD, BCACP

Latest:

Smoking Cessation: Overcoming Nicotine Dependence

Pharmacists can learn about the available interventions for smoking cessation.


Amy Law, PharmD

Latest:

Modeled Cost Differences Associated With Use of Levonorgestrel Intrauterine Devices

This analytic model assessed the per-woman cost differences between the use of 2 levonorgestrel-releasing intrauterine devices, from a US payer perspective.


Bruce C. Stuart, PhD

Latest:

Utilization Impacts of New Oral Substitutes for Parenteral Cancer-Related Therapies

Examination of changes in utilization, dose adequacy, and duration associated with market entry of the oral chelator deferasirox as a potential substitute for parenteral deferoxamine.


Steven Lucio, PharmD, BCPS

Latest:

Biosimilars: Where Are They Now?

Although biosimilars may be years away from their US debut, now is the time for pharmacists to educate themselves on this new class of agents so that they will be prepared to provide support for their appropriate use.


Kris R. Vogel, RPH

Latest:

Telepharmacy and Its Impact on Formulary Adherence

Telepharmacy is comparable to usual care in transitioning members new to an HMO onto formulary medications.


Chad Kodiak, RPh, PharmD

Latest:

Seize the Moment Now to Discuss Vaccines

Vaccines are extremely topical, with questions routinely being asked, particularly during the winter season.



Andrew Abe, PharmD

Latest:

Study Finds Icosapent Ethyl May Be Beneficial for Treating Cardiovascular Disease

Because high triglycerides have been associated with an increased risk for CVD, lowering this lab value should also reduce circulatory system risks.



Nicole Nazy, PharmD

Latest:

Hybrid Models Can Transform Team Chemistry

Morristown Medical Center’s area-based pharmacist program leads to an increase in direct patient contact and opportunities for interventions.


Don Amorosi, Chief Operating Officer

Latest:

Growth of Health System-Based Specialty Pharmacy to Continue in 2020, Reducing Cost of Care

Although the prevalence of health system-based specialty pharmacies has grown steadily over the past decade, 2020 will mark a critical year.


Sally Yowell Barbour, PharmD, BCOP, CPP

Latest:

Pharmacists on the Multidisciplinary Team: Implementing Best Practices in Chemo-Induced Nausea and Vomiting (CINV) Management

This Continuing Education activity is supported by educational grants from Eisai Inc., Merck Sharp & Dohme Corp., and Tesaro, Inc.


Michael Reppucci, RPh

Latest:

An Intermittent Reinforcement Platform to Increase Adherence to Medications

An automated reinforcement platform was shown to increase statin adherence by 34.6%.


Anyssa Garza, PharmD

Latest:

There Is an App for That

In spring 2018, the FDA approved the Dexcom G6 CGM System, an integrated continuous glucose monitoring (CGM) system for those with type 1 or type 2 diabetes who are as young as 2 years.


Noor A. Naffakh, PharmD Candidate

Latest:

House Bill Takes Aim at Direct-to-Consumer Advertising

Direct-to-consumer advertising is a continuously growing sector of the pharmaceutical industry’s cost expenditure.


Yvonne Knox, PharmD Resident

Latest:

Helping Patients Manage Cardiovascular Disease

Adherence to medications can aid in preventing and treating CVD.


George Chunderlik, RPh

Latest:

Pharmacies Need to Solve Workforce Shortages

A shortage of pharmacy technicians affects both hospitals and retail pharmacies and requires employers to focus on building a pipeline of job candidates who possess the skills they need.


John Parkinson

Latest:

Highly Contagious UK COVID-19 Variant May Become Dominant Strain by March

B.1.1.7, or otherwise known as VOC 202012/01, may lead to a large increase in the number of COVID-19 cases in the United States and may become the dominant strain of the virus in the coming months.


Jacob Glazer, PhD

Latest:

Large-Scale, Community-Based Trial of a Personalized Drug-Related Problem Rectification System

A controlled trial of a system for rectifying and preventing drug-related problems was conducted to evaluate improvement in the efficiency of resource utilization.


Richard Read Allen, MS

Latest:

Impact of Medicare Part D on Utilization and Expenditures

Examination of pharmacy behaviors before and after implementation indicated that restrictions in pharmacy benefits may not deter utilization for Part D.


Walker C. Brown, PharmD Candidate

Latest:

Case Studies (January 2020)

What could be causing this patient's involuntary, repetitive movements in her arms and legs?


Jill Murphy

Latest:

Telemedicine Can Help Facilitate Treatment for Opioid Use Disorder

Program provides a virtual assessment and treatment with buprenorphine, a medication for opioid cravings and withdrawal symptoms.